Clinical Trials Directory

Trials / Completed

CompletedNCT02793986

Dexmedetomidine vs Propofol Sedation Reduces Postoperative Delirium in Patients Receiving Hip Arthroplasty.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
296 (actual)
Sponsor
The First Affiliated Hospital of Anhui Medical University · Academic / Other
Sex
All
Age
65 Years – 85 Years
Healthy volunteers
Not accepted

Summary

With blocks of lumbar and lumbar plexus, we can reduce the intravenous anesthetics usage. To offer an satisfied surgery process for patients, a proper sedation is necessary. So in this study, we want to investigate the influence of two different sedative drugs on outcomes of patients received hip replacement surgery .

Conditions

Interventions

TypeNameDescription
DRUGpropofolFor patients in Group P, the sedation was achieved with a target-controlled infusion (TCI) of propofol, and the effect site concentration was set to 0.8-1.0μg/ml.
DRUGdexmedetomidineFor patients in Group D, the sedation was achieved with a bolus of dexmedetomidine at 1.0 μg/kg (over a period of 15 to 20 min) and followed by an infusion of dexmedetomidine at 0.2-0.7 μg/kg/h. The depth of sedation was considered enough when patient was unresponsive to voice.

Timeline

Start date
2015-08-01
Primary completion
2017-06-29
Completion
2017-06-29
First posted
2016-06-08
Last updated
2017-06-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02793986. Inclusion in this directory is not an endorsement.